![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 498/08 | |
C07D 498/18 | |||
C07K 5/08 | |||
C07K 5/10 | |||
C07K 5/12 | |||
A61K 31/40 | |||
A61K 38/06 | |||
A61K 38/07 | |||
A61K 31/12 |
(11) | Number of the document | 2086982 |
(13) | Kind of document | T |
(96) | European patent application number | 07839746.0 |
Date of filing the European patent application | 2007-10-23 | |
(97) | Date of publication of the European application | 2009-08-12 |
(45) | Date of publication and mention of the grant of the patent | 2018-08-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/022460 |
Date | 2007-10-23 |
(87) | Number | WO 2008/057209 |
Date | 2008-05-15 |
(30) | Number | Date | Country code |
854912 P | 2006-10-27 | US | |
997434 P | 2007-10-03 | US |
(72) |
LIVERTON, Nigel J., US
SUMMA, Vincenzo, IT
DI FRANCESCO, Maria Emilia, IT
FERRARA, Marco, IT
GILBERT, Kevin F., US
HARPER, Steven, IT
MCCAULEY, John A., US
MCINTYRE, Charles J., US
PETROCCHI, Alessia, IT
POMPEI, Marco, IT
ROMANO, Joseph J., US
RUDD, Michael T., US
HOLLOWAY, M Katharine, US
Butcher, John W, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
MSD Italia S.r.l., Via Vitorchiano, 151, 00189 Rome, IT |
(54) | HCV NS3 PROTEASE INHIBITORS |
HCV NS3 PROTEASE INHIBITORS |